Page 140 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 7 of 7 Original Research

24. Grimsrud A, Bygrave H, Doherty M, et al. Reimagining HIV service delivery: The 37. Boender TS, Sigaloff KCE, McMahon JH, et al. Long-term virological outcomes of
role of differentiated care from prevention to suppression. J Int AIDS Soc. first-line antiretroviral therapy for HIV-1 in low- and middle-income countries:
2016;19(1):21484. https://doi.org/10.7448/IAS.19.1.21484 A systematic review and meta-analysis. Clin Infect Dis. 2015;61(9):1453–1461.
25. World Health Organization. Consolidated guidelines on the use of antiretroviral https://doi.org/10.1093/cid/civ556
drugs for treating and preventing HIV infection: Recommendations for a public 38. Murphy R, Sunpath H, Castilla C, et al. Second-line antiretroviral therapy: Long-
health approach. 2nd ed. Geneva: WHO; 2016. term outcomes in South Africa. J Acquir Immune Defic Syndr. 2012;61(2):158–163.
26. Provincial Health Department of the Western Cape. HIV antenatal survey. 2012. https://doi.org/10.1097/QAI.0b013e3182615ad1
Cape Town: Provincial Health Department of the Western Cape; 2013. 39. Dang BN, Westbrook RA, Black WC, Rodriguez-Barradas MC, Giordano TP.
27. Stinson K, Goemaere E, Coetzee D, et al. Cohort profile: The Khayelitsha Examining the link between patient satisfaction and adherence to HIV care: A
antiretroviral programme, Cape Town, South Africa. Int J Epidemiol. 2017;46(2):e21. structural equation model. PLoS One. 2013;8(1):e54729. https://doi.org/10.1371/
https://doi.org/10.1093/ije/dyw057 journal.pone.0054729
28. Western Cape Government. City of Cape Town 2016. Socioeconomic profile 40. O’Connor JL, Gardner EM, Esser S, et al. A simple self-reported adherence tool as
[homepage on the Internet]. Cape Town: City of Cape Town; 2016. Available from: a predictor of viral rebound in people with viral suppression on antiretroviral
https://www.westerncape.gov.za/assets/departments/treasury/Documents/ therapy. HIV Med. 2016;17:124–132. https://doi.org/10.1111/hiv.12284
Socio-economic-profiles/2016/City-of-Cape-Town/city_of_cape_town_2016_ 41. Arnsten J, Demas P, Farzadegan H, et al. Antiretroviral therapy adherence and viral
socio-economic_profile_sep-lg.pdf. suppression in HIV-infected drug users: Comparison of self-report and electronic
29. Coetzeea D, Hildebranda K, Boullea A, et al. Outcomes after two years of providing monitoring. Clin Infect Dis. 2001;33(8):1417–1423. https://doi.org/10.1086/
antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18(6):887–895. 323201
https://doi.org/10.1097/00002030-200404090-00006 42. Cambiano V, Lampe F, Rodger A, et al. Use of a prescription-based measure of
30. Wilkinson L, Harley B, Sharp J, et al. Expansion of the adherence club model for antiretroviral therapy adherence to predict viral rebound in HIV-infected
stable antiretroviral therapy patients in the Cape Metro, South Africa 2011–2015. individuals with viral suppression. HIV Med. 2010;11(3):216–224. https://doi.org/
Trop Med Int Health. 2016;21(6):743–749. https://doi.org/10.1111/tmi.12699 10.1111/j.1468-1293.2009.00771.x
31. Tsondai P, Wilkinson L, Grimsrud A, Mdlalo P, Ullauri A, Boulle A. High rates of 43. Liu H, Miller L, Hays R, et al. Repeated measures longitudinal analyses of HIV
retention and viral suppression in the scale-up of antiretroviral therapy adherence virologic response as a function of percent adherence, dose timing, genotypic
clubs in Cape Town, South Africa. JIAS. 2017;20(S4):21649. https://doi.org/ sensitivity, and other factors. J Acquir Immune Defic Syndr. 2006;41(3):315–322.
10.7448/IAS.20.5.21649 https://doi.org/10.1097/01.qai.0000197071.77482.6e
32. Garone D, Conradie K, Patten G, et al. High rate of virological re-suppression 44. Phillips A, Shroufi A, Vojnov L, et al. Sustainable HIV treatment in Africa through
among patients failing second-line antiretroviral therapy following enhanced viral-load-informed differentiated care. Nature. 2015;528(7580):S68–S76. https://
adherence support: A model of care in Khayelitsha, South Africa. South Afr J HIV doi.org/10.1038/nature16046
Med. 2013;14(4):170–176. https://doi.org/10.4102/sajhivmed.v14i4.52
33. Médecins Sans Frontières. Supporting adherence to antiretroviral therapy: A 45. Manasa J, Katzenstein D, Cassol S, Newell M-L, De Oliveira T. Primary drug
resistance in South Africa: Data from 10 years of surveys. AIDS Res Hum
facility approach to reduce the risk of treatment failure [homepage on the Retroviruses. 2012;28(6):558–565. https://doi.org/10.1089/aid.2011.0284
Internet]. Report and Toolkit. Cape Town: MSF; 2012. Available from: https://
www.msf.org.za/system/tdf/risk_of_treatment_failure_mentorship_toolkit_v3.p 46. Nachega JB, Hislop M, Dowdy DW, Lo M, Regensberg L, Maartens G.
df?file=1&type=node&id=3080&force=. Accessed May 26, 2018. Adherence to highly active antiretroviral therapy assessed by pharmacy
34. Reekiem J, Mocroft A, Ledergerber B, Beniowski M, Clotet B. History of viral claims predicts survival in HIV-infected South African adults. J Acquir Immune
suppression on combination antiretroviral therapy as a predictor of virological Defic Syndr. 2006;43(1):78–84. https://doi.org/10.1097/01.qai.0000225015.
failure after a treatment change. HIV Med. 2010;10:469–478. https://doi.org/ 43266.46
10.1111/j.1468-1293.2009.00816.x 47. Johnson V, Cohen K, Wiesner L, et al. Viral suppression following switch to second-
35. Smith C, Phillips A, Dauer B, et al. Factors associated with viral rebound among line antiretroviral therapy: Associations with nucleoside reverse transcriptase
highly treatment-experienced HIV-positive patients who have achieved viral inhibitor resistance and subtherapeutic drug concentrations prior to switch.
suppression. HIV Med. 2009;10(1):19–27. https://doi.org/10.1111/j.1468-1293. J Infect Dis. 2014;209 (5):711–720. https://doi.org/10.1093/infdis/jit411
2008.00650.x 48. Tsegaye A, Wubshet M, Awoke T, Alene K. Predictors of treatment failure on
36. Decroo T, Telfer B, Dores CD, et al. Effect of Community ART Groups on retention- second-line antiretroviral therapy among adults in northwest Ethiopia: A
in-care among patients on ART in Tete Province, Mozambique: a cohort study. multicentre retrospective follow-up study. BMJ Open. 2016;6(12):e0125. https://
BMJ Open. 2017;7(8):e016800. https://doi,org/10.1136/bmjopen-2017-016800 doi.org/10.1136/bmjopen-2016-012537

http://www.sajhivmed.org.za 133 Open Access